M A Diefenbach1, R A Schnoll, S M Miller, L Brower. 1. Division of Population Science, Fox Chase Cancer Center, 510 Township Line Road, Third Floor, Cheltenham, Pennsylvania 19012, USA.
Abstract
PURPOSE: As researchers come closer to identifying the genes responsible for prostate cancer, the possibility of genetic testing for men at risk for prostate cancer becomes more likely. This study examined the following: 1) the degree to which men with (n = 43) or without (n = 83) a family history of prostate cancer would be interested in genetic testing; and 2) the degree to which interest in testing was associated with demographic, family history, and psychosocial factors. DESCRIPTION OF STUDY: Participants (N = 126) were accrued through patients who had been treated for prostate cancer at Fox Chase Cancer Center (n = 39) and through newspaper advertisements (n = 87). All participants completed a questionnaire sent by mail. RESULTS: Seventy-four percent of men were probably (50%) or definitely (24%) interested in testing. Participants with a family history of prostate cancer reported that they would be willing to pay substantially more for a genetic test compared with those without a family history. Elevated worry about prostate cancer and concerns about treatment-related side effects were associated with greater interest in genetic testing. CLINICAL IMPLICATIONS: Findings demonstrate a need for the development of genetic counseling protocols for at-risk men who are interested in genetic testing, once this test becomes available.
PURPOSE: As researchers come closer to identifying the genes responsible for prostate cancer, the possibility of genetic testing for men at risk for prostate cancer becomes more likely. This study examined the following: 1) the degree to which men with (n = 43) or without (n = 83) a family history of prostate cancer would be interested in genetic testing; and 2) the degree to which interest in testing was associated with demographic, family history, and psychosocial factors. DESCRIPTION OF STUDY: Participants (N = 126) were accrued through patients who had been treated for prostate cancer at Fox Chase Cancer Center (n = 39) and through newspaper advertisements (n = 87). All participants completed a questionnaire sent by mail. RESULTS: Seventy-four percent of men were probably (50%) or definitely (24%) interested in testing. Participants with a family history of prostate cancer reported that they would be willing to pay substantially more for a genetic test compared with those without a family history. Elevated worry about prostate cancer and concerns about treatment-related side effects were associated with greater interest in genetic testing. CLINICAL IMPLICATIONS: Findings demonstrate a need for the development of genetic counseling protocols for at-risk men who are interested in genetic testing, once this test becomes available.
Authors: Veda N Giri; Elias Obeid; Sarah E Hegarty; Laura Gross; Lisa Bealin; Colette Hyatt; Carolyn Y Fang; Amy Leader Journal: Prostate Date: 2018-04-14 Impact factor: 4.104
Authors: Kayla Collado; Sarah L Kerns; Michael A Diefenbach; Elizabeth Peterson-Roth; Raymond Koski; Harry Ostrer; Richard G Stock; Martin Mattessich; Paul Kaplan; Barry S Rosenstein Journal: Adv Radiat Oncol Date: 2020-04-18
Authors: Elyse R Park; Jamie S Ostroff; William Rakowski; Ilana F Gareen; Michael A Diefenbach; Sandra Feibelmann; Nancy A Rigotti Journal: Ann Behav Med Date: 2009-08-27
Authors: Michael J Hall; Karen J Ruth; David Yt Chen; Laura M Gross; Veda N Giri Journal: Hered Cancer Clin Pract Date: 2015-04-08 Impact factor: 2.857
Authors: U G Poehls; C C Hack; A B Ekici; M W Beckmann; P A Fasching; M Ruebner; H Huebner Journal: Eur J Med Res Date: 2018-04-27 Impact factor: 2.175
Authors: Julie N Harris; Deborah J Bowen; Alan Kuniyuki; Laura McIntosh; Liesel M FitzGerald; Elaine A Ostrander; Janet L Stanford Journal: Genet Med Date: 2009-05 Impact factor: 8.822